CEERI VACCINE RESEARCH SITE NETWORK

Our global network has a long-standing record of leading the fight against devastating pandemics and enduring health threats. We developed our proven expertise and flexible capacity by responding to international health crises, ensuring crucial research is available when it is needed most.

About CEERI Vaccine Research Site Network

The CEERI Vaccine Research Site Network stands as a premier global alliance, meticulously curated to bring together top-tier clinical investigation sites. Our network is comprised of leading academic institutions, private research centers, and hospital systems, fostering a collaborative environment dedicated to advancing vaccine research.

With a significant global footprint, we operate across key regions including Central & Eastern Europe (CEE), the Middle East & North Africa (MENA), Southeast Asia (SEA), and the Gulf Cooperation Council (GCC) countries. Our member sites are selected based on their unwavering commitment to scientific excellence, robust operational capabilities, and a proven history of successfully enrolling participants in complex vaccine studies.

Our Global Impact

20+

Years of Research Experience

30+

Countries

1,000+

Medical facilities across our network

4,000+

Investigators

200,000+

Participants Enrolled

Advantages of Partnering with CEERI

Cost-Efficiency

Shared infrastructure, standardized procedures, and centralized resources reduce overall trial costs.

Diversity of Patient Population

Networks expand recruitment reach across regions, ensuring inclusion of varied demographics and disease prevalence.

Access to Large Patient Population

The CEERI Vaccine Research Site Network provides direct access to a large and diverse patient population

Time-Saving Through Local Process Expertise

Sites familiar with national and regional regulatory, ethical, and operational processes streamline study initiation and execution.

Consistency & Quality

Harmonized protocols and standardized training across the network ensure reliable and comparable data.

Rapid Study Start-Up

Pre-established infrastructure, trained personnel, and experienced investigators allow faster trial initiation.

Long-Term Sustainability

Networks foster ongoing collaborations, making sites 'trial-ready' for future vaccine studies.

Proven on the Front Lines of Every Modern Health Crisis

For decades, our consortium has been at the forefront, battling the world's most pressing pandemics and endemic threats. Our deep experience and agile network were forged during fighting the global health emergencies, delivering critical clinical research when it matters most.

Our Pandemic Response Experience

H1N1 (Swine Flu) - 2009

MERS (Middle East Respiratory Syndrome)

Rapidly enrolled participants in large-scale efficacy trials during the 2009 pandemic, helping to accelerate vaccine availability.

Conducted pivotal research in the core region of the outbreak, contributing to the understanding of coronavirus vaccines and therapeutics.

Zika Virus

COVID-19

Executed studies in affected regions like South America, focusing on prevention and understanding the pathogen's impact.

A comprehensive, global effort supporting a diverse portfolio of vaccines and therapeutics across our entire network.

Vaccine Trials Leadership

Covid-19 Vaccine

CEERI Vaccine Research Site Network was a leader in the recent pandemic fight in vaccine and treatment development, working with Pfizer-BioNTech COVID-19 vaccine, Health Institutes of Turkey (TUSEB), Sinovac Biotech and Gamaleya Research Institute on their vaccine studies.

A study on the immune response and safety of a combined measles, mumps, rubella, chickenpox vaccine compared to a marketed combined vaccine

Chickenpox Vaccine

RSV Vaccine

A Phase 3 Study To Evaluate The Efficacy, Immunogenicity, And Safety Of Respiratory Syncytial Virus (RSV) Prefusion F Subunit Vaccine In Adults

Omicron-specific Vaccine

Assess the efficacy of a targeted vaccine against the Omicron variant

Lyme Disease Vaccine

Safety Study of a Lyme Disease Vaccine in Healthy Children

Mpox Vaccine

Evaluate safety and immunogenicity of Sinopharm's mpox vaccine